Jacobs & Co
- SEC CIK
- 0001055544
- Latest filing
- Jul 8, 2026
GSK holding history
GSK plc in every 13F filed by Jacobs & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GSK overviewAll 13F holders of GSKFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 15
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −96,753−100.0% | Sold out | Holders |
| Q3 2024 | 96,753 | $3.96M | 0.4% | −42,490−30.5% | Reduced | Holders |
| Q2 2024 | 139,243 | $5.36M | 0.6% | −6,477−4.4% | Reduced | Holders |
| Q1 2024 | 145,720 | $6.25M | 0.7% | −4,429−2.9% | Reduced | Holders |
| Q4 2023 | 150,149 | $5.56M | 0.6% | −3,836−2.5% | Reduced | Holders |
| Q3 2023 | 153,985 | $5.58M | 0.7% | −1,813−1.2% | Reduced | Holders |
| Q2 2023 | 155,798 | $5.55M | 0.7% | −2,427−1.5% | Reduced | Holders |
| Q1 2023 | 158,225 | $5.63M | 0.7% | −4,142−2.6% | Reduced | Holders |
| Q4 2022 | 162,367 | $5.71M | 0.7% | +5,652+3.6% | Added | Holders |
| Q3 2022 | 156,715 | $4.61M | 0.7% | −36,763−19.0% | Reduced | Holders |
| Q2 2022 | 193,478 | $8.42M | 1.1% | −3,639−1.8% | Reduced | Holders |
| Q1 2022 | 197,117 | $8.59M | 1.0% | −718−0.4% | Reduced | Holders |
| Q4 2021 | 197,835 | $8.72M | 0.9% | −840−0.4% | Reduced | Holders |
| Q3 2021 | 198,675 | $7.59M | 0.9% | +12,672+6.8% | Added | Holders |
| Q2 2021 | 186,003 | $7.41M | 0.9% | +6,337+3.5% | Added | Holders |
| Q1 2021 | 179,666 | $6.41M | 0.8% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.